Healthcare and Medical IoT
Author(s)
Datta, Shoumen
Date Issued
April 6, 2017
Abstract
Detection of analytes in the context of nano-diagnostics for preventive medicine and global public health may be within our grasp. But, it appears to be far removed from the reality of the world where 80% of the people live (non-OECD nations). The 80% of the world, however, cannot ignore other afflictions, for example, cancer, diabetes, cardiovascular malfunctions and pulmonary diseases, to name a few. Which means, in the biomedical domain, the rest of the world must find ways to use therapeutic advances, for example, human induced adult pluripotent stem cells, plant based bio-pharmaceuticals, traditional biologics (monoclonal antibody producing autologous cells), metabolomic sensor networks (in vivo wireless communication networks monitoring analytes and transmitting data from inside the body), molecular robotics (ingested micro-machines removing intestinal polyps) and nano-machines for targeted apoptosis, precision cell death and time-sensitive drug delivery.
Description
11 million children die each year from preventable causes. 70% of the deaths are due to 6 well documented diseases/causes. The mortality is concentrated in 10 countries. We have the tools and technologies to address this problem.
Subjects
Healthcare, Public Health, Global Disease Burden, IoT, Nano-sensors, Mobile, 3D, Stem
MIT Department
Massachusetts Institute of Technology. Auto-ID Laboratory
Terms of Use
Attribution-NonCommercial-NoDerivs 3.0 United States
Persistent DSpace Link
